Genzyme's Chris Wallace on Temperature Controlled Distribution to Small Patient Pools and Change Management in the End-to-End Supply Chain
Add bookmark
Genzyme's Chris Wallace on Temperature Controlled Distribution to Small Patient Pools and Change Management in the End-to-End Supply Chain
Add bookmark"A problem shared is a problem minimised." In this podcast Chris Wallace, Distribution Director, Europe at Genzyme, speaks to Andrea Charles, Editor for Cold Chain IQ, live at IQPC's Nordic Pharmaceutical Supply Chain Forum . Wallace shares his insights on trends in the end-to-end supply chain, the challenges of temperature controlled distribution for rare disease products and his experiences of re-engineering the supply chain
[inlinead]
| Have Your Say Rate this feature and give us your feedback in the comments section below |
Tags:
Chris Wallace
Genzyme
temperature controlled distribution
rare diseases
Sanofi
change management
end-to-end supply chain
